New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
10:37 EDTALLT, CHGG, MSTX, ZGNX, SALE, CVC, DLPHHigh option volume stocks
High option volume stocks: ALLT CHGG MSTX NBL ZGNX SALE JNUG CVC DLPH
News For ALLT;CHGG;MSTX;ZGNX;SALE;CVC;DLPH From The Last 14 Days
Check below for free stories on ALLT;CHGG;MSTX;ZGNX;SALE;CVC;DLPH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
16:27 EDTZGNXZogenix gets exclusive licensing for Zohydro ER from Daravita
Subscribe for More Information
08:40 EDTZGNXZogenix reports new data shows Zohydro ER reduced pain, improved function
Subscribe for More Information
September 15, 2014
07:26 EDTMSTXPiper Jaffray to hold a conference
Subscribe for More Information
September 10, 2014
10:00 EDTCVCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:04 EDTCVCCablevision initiated with a Hold at Canaccord
Target $19.
September 9, 2014
09:02 EDTDLPHDelphi Automotive president and CEO Rodney O'Neal to retire March 1, 2015
Subscribe for More Information
September 8, 2014
13:26 EDTDLPHFord falls after two notch downgrade at Morgan Stanley
Subscribe for More Information
08:01 EDTMSTXMast Therapeutics announces positive results from Phase 2 study of AIR001
Mast Therapeutics reported top-line results from a Phase 2 study of AIR001 inhalation solution for the treatment of pulmonary arterial hypertension. Mast obtained the rights to the AIR001 program through its acquisition of privately-held Aires Pharmaceuticals earlier this year. In the primary efficacy analysis of the Phase 2 study, all doses showed improvement in median pulmonary vascular resistance. In the secondary efficacy analysis, all doses showed improvements in the median distances obtained in the 6-minute walk test, including clinically-meaningful improvements at the highest dose level. Additionally, AIR001 was well-tolerated, with no treatment related serious adverse events. In particular, methemoglobin levels remained normal, which distinguishes AIR001 from safety concerns associated with intravenously-administered nitrite.
07:59 EDTDLPHMorgan Stanley downgrades Auto sector to Cautious, downgrades Ford
Subscribe for More Information
06:05 EDTALLTAllot Communications receives expansion order of $15M from Tier-1 operator
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use